featured
Combination Therapies for Bridging Fibrosis and Cirrhosis Attributable to NASH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Hepatology 2021 Feb 01;73(2)625-643, R Loomba, M Noureddin, KV Kowdley, A Kohli, A Sheikh, G Neff, BR Bhandari, N Gunn, SH Caldwell, Z Goodman, I Wapinski, M Resnick, AH Beck, D Ding, C Jia, JC Chuang, RS Huss, C Chung, GM Subramanian, RP Myers, K Patel, BB Borg, R Ghalib, H Kabler, J Poulos, Z Younes, M Elkhashab, T Hassanein, R Iyer, P Ruane, ML Shiffman, S Strasser, VW Wong, N AlkhouriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.